About 200 reports

  • BIOMARKER
  • BY CIRCULATING BIOMARKER - FORECAST FOR LIQUID BIOPSY MARKET SHARE (PERCENT), 2018 - 2025

The global liquid biopsy market is expected to surpass US$ 5 Billion mark by 2025. Liquid biopsy is a non-invasive technology that detects molecular biomarkers using liquid sample without the need for costly or invasive procedures. The abilities of liquid biopsy like, easy and minimal invasiveness, early cancer diagnosis & detection, characterization...

  • Biomarker
  • World
  • Forecast
  • Market Size
  • MDxHealth SA
  • CIRCULATING BIOMARKERS
  • LIQUID BIOPSY: DETECTION OF CANCER BIOMARKERS

Global breast cancer liquid biopsy market projected to grow at a CAGR of 23.1% The global breast cancer liquid biopsy market is estimated to grow at a CAGR of 23.1% from 2017 to 2022, from USD 145.4 million in 2017 to reach USD 411.1 million by 2022. Increasing prevalence of breast cancer, increasing preference for noninvasive...

  • Biomarker
  • United States
  • Market Size
  • Biocept, Inc.
  • Biodesix Inc.
  • CANCER BIOMARKERS MARKET, BY APPLICATION
  • BIOMARKER MARKET FOR PCR

The biomarker technologies market is projected to grow at a CAGR of 9.7%. The biomarker technologies market is expected to reach USD 74.51 billion in 2022 from USD 46.97 billion in 2017, at a CAGR of 9.7% during the forecast period The growth of this market is mainly driven by increasing healthcare expenditure and...

  • Biomarker
  • North America
  • United States
  • World
  • Market Size

Business Overview Financials List of Tables Summary Table A : Global Market for Biomarkers, by Segment, Through 2023 Summary Table B : Global Market for Biomarkers, by Type, Through 2023 Summary Table C : Global Market for Biomarkers, by Therapeutic Area, Through 2023 Summ

  • Biomarker
  • Genomics
  • World

Biomarkers List of Tables Summary Table A : Global Cardiac Biomarker Market, by Biomarker Type, Through 2022 Summary Table B : Global Cardiac Biomarker Market Share, by Region, 2017 Table ## : Standard Angina Pectoris Classification Table ## : Top ## Leadin

  • Biomarker
  • Genomics
  • World
  • Market Shares
  • BIOMARKER
  • BIOMARKERS

The Global Biomarker Partnering Terms and Agreements 2010-2018: Deal trends, players and financials report provides comprehensive understanding and unprecedented access to the biomarker partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in biomarker partnering deals Biomarker...

  • Biomarker
  • Genomics
  • World
  • Demand

Global Cardiac Biomarkers Industry CARDIAC BIOMARKERS MCP-## A GLOBAL STRATEGIC BUSINESS REPORT CONTENTS ##.

  • Biomarker
  • Point Of Care Testing
  • APAC
  • Company Financials
  • Market Size
  • Increasing use of cardiac biomarkers
  • Emerging cardiac biomarkers

About Cardiac Biomarkers Cardiac biomarkers are the substances used to detect the risk stratification of a patient with chest pain or suspected acute coronary syndrome (ACS). These biomarkers are released in blood when the heart is damaged or stressed. The tests that are carried out by introducing the cardiac biomarkers to the...

  • Biomarker
  • World
  • Market Size
  • Alere Inc.
  • F. Hoffmann-La Roche Ltd.

GLOBAL CANCER BIOMARKER MARKET FORECAST 2017-2025 ##.

  • Biomarker
  • Cancer Biomarker
  • Genomics
  • World
  • Market Size

GLOBAL CENTRAL NERVOUS SYSTEM BIOMARKERS MARKET FORECAST 2017-2025 ##.

  • Biomarker
  • Genomics
  • World
  • Forecast
  • Market Size

Cancer Biomarkers Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025 ##.

  • Biomarker
  • Cancer Biomarker
  • APAC
  • World
  • Market Size

Imaging biomarkers has also come up as one attractive biomarker type, which is expected to witness growth at a high rate in the years coming ahead.

  • Biomarker
  • Genomics
  • Forecast
  • Market Size

Some of the prominent trends that the market is witnessing include rising use of cardiac biomarkers in poc testing, emerging cardiac biomarkers and technological advancements using cardiac biomarkers combinations.

  • Biomarker
  • United States
  • Forecast
  • Market Size

Multiplex Biomarker Imaging Market: North America Expected to be the Most Attractive Regional Market During the Forecast Period: Global Industry Analysis 2012 - 2016 and Opportunity Assessment 2017 - 2027 ##.

  • Biomarker
  • Forecast
  • Market Size
  • Global neurological biomarkers market 2015
  • Market penetration of key neurological biomarkers manufacturers 2015

About Biomarkers Biomarkers are the indicators considered for identifying specific diseases. They are mainly used for identification of the progress of a particular disease and evaluation of an effective method for drug target identification. The biomarkers specifically involved in the identification of the neurological disorders are...

  • Biomarker
  • World
  • Market Size
  • QIAGEN N.V.
  • Thermo Fisher Scientific, Inc.

One Way Liver S. L. ##. ##. ##. ##.

  • Biomarker
  • Digestive System Disorder
  • Genomics
  • World
  • Market Size

Biomarkers Enabling Diabetes and Obesity Management ##. ##. ## EXECUTIVE SUMMARY ##. ## Executive Summary ##. ## Scope of Research ##. ## Research Methodology ##. ## Key Findings ##. ##. ## ROLE OF BIOMARKERS IN DIABETES AND OBESITY MANAGEMENT ##. ## Role of Biomarkers in Diabetes and

  • Biomarker
  • Diabetes
  • Genomics
  • World
  • Forecast

Global Cancer Biomarkers Market Research and Analysis 2015-2022 ##.

  • Biomarker
  • Cancer Biomarker
  • Genomics
  • APAC
  • World

MARKET ##.

  • Biomarker
  • APAC
  • United States
  • Company Financials
  • Market Size

NASH Biomarkers Market Analysis By Type, By End-Use And Segment Forecasts, 2014 - 2025 Table of Contents Chapter ## Research Methodology ##. ## Country wise market: Base estimates ##. ## Global market: CAGR calculation ##. ## Region based segment share calculation ##. ## Research Scope & As

  • Biomarker
  • Genomics
  • United States
  • Demand
  • 5 LIQUID BIOPSY GLOBAL MARKET, BY BIOMARKER
  • GERMANY LIQUID BIOPSY MARKET REVENUE, BY BIOMARKERS

Liquid biopsy is process of obtaining non-solid tissue usually the blood and other body fluids (urine, saliva etc. ) obtained non-invasively as a diagnosis and monitoring tool for disease such as cancer through identification of biomarker in form of cell-fee DNA or circulating tumor cells (CTC) to advance personalized...

  • Biomarker
  • World
  • Market Size
  • Biocept, Inc.
  • Guardant Health, Inc.

LIST OF TABLES ##.

  • Biomarker
  • Cancer Biomarker
  • Genomics
  • World
  • Market Size

This study investigates one of the most important market drivers: the introduction of combination therapies, which are expected to continue to contribute substantially to market growth through the forecast period.

  • Biomarker
  • Genomics
  • World
  • Forecast

Cancer Biomarker Market Analysis By Type (Breast, Prostate, Colorectal, Cervical, Liver, Lung Cancer), By Biomolecule (Genetic, Epigenetic, Metabolic, Proteomic), By Application, And Segment Forecasts, 2014 - 2025 Table of Contents Chapter ##.

  • Biomarker
  • Cancer Biomarker
  • United States
  • Forecast
  • Market Size

COMPANY PROFILE ##.

  • Biomarker
  • Chronic Disease
  • Genomics
  • World
  • Market Size

List of Tables Table ## Global Biomarkers Market By Geography, Market Forecast (2015-2025) (US$ MN) Table ## Global Biomarkers Market By Disease Indication, Market Forecast (2015-2025) (US$ MN) Table ## Global Biomarkers Market By Type, Market Forecast (2015-2025) (U

  • Biomarker
  • APAC
  • World
  • Forecast
  • Market Size

Market Categorization ##: Cardiac Biomarkers Type Estimates & Trend Analysis ##. ##.

  • Biomarker
  • Genomics
  • United States
  • Demand
  • Market Size
  • Cancer Biomarkers
  • Global Cancer Biomarkers Market

About Cancer Biomarkers Biomarkers are molecules present in the blood, other body fluids such as serum, urine, or in tissue that are indicators of a disease or abnormal conditions. Biomarkers are mostly used as diagnostic tools. Biomarkers help in identifying potential drug failures in initial stages, leading to savings in time and costs....

  • Biomarker
  • Abbott Laboratories, Inc.
  • Affymetrix, Inc.
  • Illumina, Inc.
  • QIAGEN N.V.

By efficacy biomarkers, the market is further divided into prognostic biomarkers, surrogate biomarkers, predictive biomarkers and pharmacodynamic biomarkers.

  • Biomarker
  • Genomics
  • United States
  • Forecast
  • Market Size

Patient treatment and diagnostic model It is ‘one-drug-one-diagnostic’ model.

  • Biomarker
  • Genomics
  • World
  • Forecast